SCHEMBL7633968

SCHEMBL7633968

CCCCC(C(=O)O)(c1ccccc1)[PH](=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 2/20 0.37
MAPT P10636 1/20 0.37
CES2 O00748 3/20 0.37
CES1 P23141 3/20 0.37
TSHR P16473 1/20 0.37
DRD2 P14416 1/20 0.36
OPRM1 P35372 1/20 0.36
DRD3 P35462 1/20 0.36
GAA P10253 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
CYP1A2 P05177 2/20 0.35
ESR1 P03372 2/20 0.35
ESR2 Q92731 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7639980 0.95 GAA (0.41) KIF11ALDH1A1CES2CES1TSHR
SCHEMBL7644315 0.81 GRM2 (0.44) TDP1MAPTCES1NPC1RAB9A
SCHEMBL3927998 0.75 ALDH1A1 (0.52) KIF11L3MBTL1KMT2ATDP1ALDH1A1
SCHEMBL8046600 0.75 GRM2 (0.41) L3MBTL1MAPTOPRM1NAAARAB9A
SCHEMBL27572321 0.74 OPRM1 (0.49) KIF11L3MBTL1KMT2ATDP1ALDH1A1
SCHEMBL2517312 0.74 KIF11 (0.48) KIF11L3MBTL1KMT2ATDP1ALDH1A1
SCHEMBL6478875 0.74 KIF11 (0.48) KIF11L3MBTL1KMT2ATDP1ALDH1A1
SCHEMBL28003885 0.74 KIF11 (0.48) KIF11L3MBTL1KMT2ATDP1ALDH1A1
SCHEMBL8059153 0.74 GRM2 (0.40) L3MBTL1MAPTOPRM1NAAARAB9A
SCHEMBL11795626 0.73 KIF11 (0.48) KIF11L3MBTL1KMT2ATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed